苑东生物
(688513)
| 流通市值：71.85亿 | | | 总市值：71.85亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 305,640,342.42 | 1,349,755,302.66 | 1,039,937,156.56 | 669,513,693.52 |
| 营业收入 | 305,640,342.42 | 1,349,755,302.66 | 1,039,937,156.56 | 669,513,693.52 |
| 二、营业总成本 | 259,521,097.68 | 1,161,906,337.64 | 858,787,446.13 | 543,480,539.83 |
| 营业成本 | 63,711,307.96 | 338,445,876.86 | 233,451,947.3 | 149,126,238.02 |
| 税金及附加 | 4,182,466.28 | 20,990,079.9 | 15,744,472.83 | 10,347,928.72 |
| 销售费用 | 110,616,491.3 | 445,787,301.63 | 353,893,867.87 | 236,568,520.74 |
| 管理费用 | 21,742,223.94 | 107,145,595.11 | 73,056,791.44 | 43,469,812.24 |
| 研发费用 | 61,097,854.94 | 263,855,882.16 | 188,129,351.01 | 108,931,264.31 |
| 财务费用 | -1,829,246.74 | -14,318,398.02 | -5,488,984.32 | -4,963,224.2 |
| 其中:利息费用 | 720,341.73 | 3,682,764.05 | 2,977,621.7 | 2,181,191.13 |
| 其中:利息收入 | 2,606,210.22 | 17,541,463.48 | 8,357,080.35 | 6,876,759.49 |
| 加:公允价值变动收益 | 3,436,962.88 | 14,923,057.38 | 13,500,280.18 | 9,099,774.42 |
| 加:投资收益 | 1,021,187.84 | 9,841,891.62 | 4,791,902.45 | 4,593,293.23 |
| 资产处置收益 | - | -2,992.06 | -2,294.24 | -2,294.24 |
| 资产减值损失(新) | -804,911.88 | -5,698,289.79 | -1,740,562.67 | -669,631.16 |
| 信用减值损失(新) | 2,803.4 | -3,052,666.28 | -5,915,009.12 | -5,417,544.21 |
| 其他收益 | 12,693,796.74 | 48,120,498.3 | 39,768,199.3 | 25,954,090.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 62,469,083.72 | 251,980,464.19 | 231,552,226.33 | 159,590,841.83 |
| 加:营业外收入 | 9,793.09 | 1,388,875 | 9,351.68 | 679.27 |
| 减:营业外支出 | 66,326.56 | 781,030.96 | 192,367.83 | 135,164.65 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 62,412,550.25 | 252,588,308.23 | 231,369,210.18 | 159,456,356.45 |
| 减:所得税费用 | 1,822,198.61 | 14,354,148.93 | 14,345,612.26 | 12,964,003.58 |
| 六、净利润 | 60,590,351.64 | 238,234,159.3 | 217,023,597.92 | 146,492,352.87 |
| 持续经营净利润 | 60,590,351.64 | 238,234,159.3 | 217,023,597.92 | 146,492,352.87 |
| 归属于母公司股东的净利润 | 60,590,351.64 | 238,234,159.3 | 217,023,597.92 | 146,492,352.87 |
| (一)基本每股收益 | 0.34 | 1.36 | 1.24 | 0.83 |
| (二)稀释每股收益 | 0.34 | 1.36 | 1.24 | 0.83 |
| 九、综合收益总额 | 60,590,351.64 | 238,234,159.3 | 217,023,597.92 | 146,492,352.87 |
| 归属于母公司股东的综合收益总额 | 60,590,351.64 | 238,234,159.3 | 217,023,597.92 | 146,492,352.87 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |